Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

Abemaciclib/denosumab/fulvestrant

Diarrhoea and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Aoyagi H, et al. [A Case of Disseminated Myelocarcinoma with Bone Metastasis 15 Years after Mastectomy and Relatively Long-Term Survival through Multidisciplinary Treatment]. [Japanese]. Gan to Kagaku Ryoho 48: 1592-1594, No. 13, Dec 2021. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/35046266/ [Japanese; summarised from a translation] Aoyagi H, et al. [A Case of Disseminated Myelocarcinoma with Bone Metastasis 15 Years after Mastectomy and Relatively Long-Term Survival through Multidisciplinary Treatment]. [Japanese]. Gan to Kagaku Ryoho 48: 1592-1594, No. 13, Dec 2021. Available from: URL: https://​pubmed.​ncbi.​nlm.​nih.​gov/​35046266/​ [Japanese; summarised from a translation]
Metadaten
Titel
Abemaciclib/denosumab/fulvestrant
Diarrhoea and lack of efficacy: case report
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-15743-6

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Octreotide

Case report

Tacrolimus

Case report

Prednisone